Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Summary

Excerpt
 

The TCGA Renal Phenotype Research Group is part of the CIP TCGA Radiology Initiative focused on analyzing images from the TCGA-KIRC collection. Multiple modalities of images which correlate to the kidney renal clear cell carcinoma (KIRC) data in the TCGA Data Portal are currently being gathered for submission to TCIA.

...

  • Identify unique patterns of genomic changes that divide clear cell and papillary carcinoma tumors into subgroups
  • Identify genomic differences that distinguish tumors across gender, race or ethnicity
  • Determine if specific patterns of genomic changes are connected to tumor recurrence after therapy

Research and Publications

Data Source

Status

TCGA Data Portal Publication Guidelines

No restrictions; all data available without limitations

TCIA Data Usage Policies and Restrictions

No restrictions; all data available without limitations

Please contact us at cancerimagingarchive@mail.nih.gov if you have any questions about these policies, or would like to join our public mailing list and be kept in the loop about new data releases and other related news as this effort moves forward.

TCGA-KIRC Marker Paper and Image Source Sites (ISS)

Imaging Source Site (ISS) Groups will be populated and governed by participants from institutions that have provided imaging data to the archive for a given cancer type. Modeled after TCGA analysis groups, these groups are given the opportunity to publish a marker paper for a given cancer type per the aforementioned publication policy. It is hoped that this will generate increased participation in the building of these multi-institutional data sets that become an open community resource.  Current TCGA-KIRCsource sites include:

...

Please contact Dr. Oguz Akin (akino@mskcc.org) if you have scientific questions you would like to direct to the TCGA-KIRC ISS or are interested in collaborating with their group.

References

The following links contain publications from the main TCGA project, as well as their posted publication guidelines.

2nd Annual TCGA Symposium

  • Adverse Outcomes in Clear Cell Renal Cell Carcinoma With Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2
    • Ari Hakimi, MD, Memorial Sloan-Kettering Cancer Center
    • Video | Slides
  • TCGA Clear Cell Renal Cell Carcinoma Project
    • Chad J. Creighton, PhD, Baylor College of Medicine
    • Video | Slides